Cargando…

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer

This study is aimed at exploring the potential mechanism of the PPAR signaling pathway in breast cancer (BRCA) and constructing a novel prognostic-related risk model. We used various bioinformatics methods and databases to complete our exploration in this research. Based on TCGA database, we use mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yingkun, Shu, Dan, Shen, Meiying, Wu, Qiulin, Peng, Yang, Liu, Li, Tang, Zhenrong, Gao, Shun, Wang, Yuan, Liu, Shengchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184151/ https://www.ncbi.nlm.nih.gov/pubmed/35692496 http://dx.doi.org/10.1155/2022/9412119

Ejemplares similares

Characterization of starvation response‐related genes for predicting prognosis in breast cancer
por: Wang, Yuan, et al.
Publicado: (2023)

A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer
por: Wang, Yuan, et al.
Publicado: (2023)

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients
por: Xu, Yingkun, et al.
Publicado: (2022)

Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis
por: Liu, Li, et al.
Publicado: (2022)

Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients
por: Xu, Yingkun, et al.
Publicado: (2022)

Comprehensive Analysis of Necroptosis-Related Genes as Prognostic Factors and Immunological Biomarkers in Breast Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma
por: Yu, Haochen, et al.
Publicado: (2022)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
por: Peng, Yang, et al.
Publicado: (2021)

MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer
por: Li, Han, et al.
Publicado: (2022)

An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer
por: Gao, Shun, et al.
Publicado: (2023)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021)

Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

Development and validation of a novel 15‐CpG‐based signature for predicting prognosis in triple‐negative breast cancer
por: Peng, Yang, et al.
Publicado: (2020)

Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Qu, Fanli, et al.
Publicado: (2020)

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study
por: Tang, Lingfeng, et al.
Publicado: (2022)

Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients
por: Wang, Yihua, et al.
Publicado: (2021)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
por: Wang, Yihua, et al.
Publicado: (2021)

A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature
por: Wang, Yihua, et al.
Publicado: (2020)

Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer
por: Zhang, Yan, et al.
Publicado: (2023)

The Expression of PPAR Pathway-Related Genes Can Better Predict the Prognosis of Patients with Colon Adenocarcinoma
por: Zhou, Xiao-Yu, et al.
Publicado: (2022)

Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy
por: Lan, Ailin, et al.
Publicado: (2023)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
por: Sun, Yonghao, et al.
Publicado: (2022)

Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
por: Chen, Rui, et al.
Publicado: (2018)

Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma
por: Xu, Wenfang, et al.
Publicado: (2021)

Construction and validation of a chemokine family-based signature for the prediction of prognosis and therapeutic response in colon cancer
por: Zhang, Wen, et al.
Publicado: (2023)

Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients
por: Ma, Jian-Ying, et al.
Publicado: (2021)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

Study of the Antimicrobial Activity of the Chinese Dong Ethnic Minority Medicine, Madeng'ai
por: Tang, Zhenrong, et al.
Publicado: (2022)

Fabrication of avidin-stabilized gold nanoclusters with dual emissions and their application in biosensing
por: Tang, Zhenrong, et al.
Publicado: (2022)

Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer
por: Xu, Yingkun, et al.
Publicado: (2022)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer
por: Liu, Qin, et al.
Publicado: (2021)

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Construction and validation of an aging‐related gene signature for prognosis prediction of patients with breast cancer
por: Li, Jian, et al.
Publicado: (2022)

Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer
por: Lan, Ailin, et al.
Publicado: (2022)

Detection of gene pathways with predictive power for breast cancer prognosis
por: Ma, Shuangge, et al.
Publicado: (2010)

Development and Validation of a Prediction Model for Predicting the Prognosis of Postoperative Patients with Hepatocellular Carcinoma
por: Liu, Xiaoliang, et al.
Publicado: (2022)

Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer
por: Li, Huamei, et al.
Publicado: (2022)

Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer
por: Qu, Fanli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5vrf0p6g9n2q4me2qb1v0u1cqd